A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (Q3019496)

From MaRDI portal
Revision as of 23:15, 19 March 2024 by Openalex240319060354 (talk | contribs) (Set OpenAlex properties.)
scientific article
Language Label Description Also known as
English
A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches
scientific article

    Statements

    A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (English)
    0 references
    0 references
    28 July 2011
    0 references
    dose escalation
    0 references
    MTD
    0 references
    Bayesian
    0 references
    maximum likelihood
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references